An immunomodulatory peptide derived from the thymus gland, approved in several countries for hepatitis B/C and studied for immune enhancement in cancer and infectious diseases.
Future cardiology|2025|Liu H et al.
This multicenter randomized controlled trial evaluates the efficacy of thymosin alpha 1 (Tα1) supplementation in preventing organ dysfunction following acute type A aortic dissection (ATAAD) repair. Over 330 patients will be equally assigned to recei…
PMID: 40367062
Frontiers in microbiology|2025|Ahmad B et al.
The hybrid FowlTα1 peptide represents a promising biomolecule synthesized from two naturally occurring peptides, namely Fowlicidins (Fowl) and Thymosin α1 (Tα1). This particular peptide exhibits remarkable anti-inflammatory and antimicrobial properti…
PMID: 40309114
iScience|2025|Deng S et al.
The strong immunosuppression and immune evasion of pancreatic ductal adenocarcinoma (PDAC) result in poor efficacy of immune checkpoint blockade. In this study, the PD-1 level on CD8T cells in the peripheral blood of patients with PDAC was significan…
PMID: 40727936
Scientific reports|2025|Yao S et al.
To validate the efficacy and safety of thymosin α-1 combined with lenvatinib plus sintilimab in the treatment of unresectable hepatocellular carcinoma. Patients with unresectable hepatocellular carcinoma treated with lenvatinib plus sintilimab at the…
PMID: 40263352
Translational lung cancer research|2025|Zhang H et al.
BACKGROUND: Concurrent chemoradiotherapy (CCRT) followed by consolidative immunotherapy represents the standard of care for unresectable locally advanced non-small cell lung cancer (LA-NSCLC), but critical challenges persist: a considerable number of…
PMID: 40799433
Clinical therapeutics|2025|Cao S, Han P
OBJECTIVES: Sepsis, a multifaceted disorder, emerges from dysregulated host response to infection, culminating in organ dysfunction and heightened risk of mortality. Present umbrella systematic review was conducted to impart accurate data regarding t…
ReviewMeta-Analysis
PMID: 40055068
International journal of immunopathology and pharmacology|2025|Gao C et al.
INTRODUCTION: Patients with locally advanced gastric cancer often face postoperative complications and insufficient short-term outcomes. Understanding the changes in peripheral lymphocyte subsets following laparoscopic D2 gastrectomy is critical to a…
PMID: 40650581
Brain, behavior, & immunity - health|2025|Aynekulu Mersha D et al.
BACKGROUND: A considerable proportion (21%) of patients with common variable immunodeficiency (CVID) suffers from depression. These subjects are characterized by reduced naïve T cells and a premature T cell senescence similar to that of patients with…
PMID: 39867848
BMJ (Clinical research ed.)|2025|Wu J et al.
OBJECTIVE: To evaluate whether the immunomodulatory drug thymosin α1 reduces mortality in adults with sepsis. DESIGN: Multicentre, double blinded, placebo controlled phase 3 trial. SETTING: 22 centres in China, September 2016 to December 2020. PARTIC…
Randomized Controlled Trial
PMID: 39814420
Journal for immunotherapy of cancer|2024|Tang S et al.
BACKGROUND: Liver metastasis is highly aggressive and immune tolerant, and lacks effective treatment strategies. This study aimed to develop a neoantigen hydrogel vaccine (NPT-gels) with high clinical feasibility and further investigate its efficacy…
Animal Study
PMID: 39694701
Gut and liver|2024|Huang X et al.
BACKGROUND/AIMS: Metabolic syndrome is common in patients with acute pancreatitis and its components have been reported to be associated with infectious complications. In thisanalysis, we aimed to evaluate whether metabolic abnormalities impact the e…
Randomized Controlled Trial
PMID: 38356344
BMJ open|2024|Kong Y et al.
INTRODUCTION: The PRaG regimen, which consists of hypofractionated radiotherapy combined with a programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitor and granulocyte-macrophage colony stimulating factor (GM-CSF), has been demo…
PMID: 38458816
American journal of translational research|2024|Guo X et al.
BACKGROUND: BRII-196 and BRII-198 are two recombinant human immunoglobulin (Ig) G1 monoclonal antibodies (mAbs) that non-competitively target distinct epitope regions within the receptor-binding domain (RBD) of the coronavirus spike glycoproteins. Th…
Animal Study
PMID: 38586111
American journal of translational research|2024|Shi F et al.
OBJECTIVE: To observe the effect of thymalfasin on myeloid-derived suppressor cells (MDSCs) subsets in peripheral blood of patients with non-small cell lung cancer (NSCLC). METHODS: 50 cases of NSCLC (NSCLC group) diagnosed in Chest Hospital of Jiang…
PMID: 38883367
Frontiers in medicine|2024|Garaci E et al.
Phenotypic drug discovery (PDD) involves screening compounds for their effects on cells, tissues, or whole organisms without necessarily understanding the underlying molecular targets. PDD differs from target-based strategies as it does not require k…
Review
PMID: 38903817
Medicine|2024|Yu J et al.
RATIONALE: Triple-negative breast cancer is characterized by a worse prognosis compared with other breast cancer subtypes, especially in the case of pretreated metastatic triple-negative breast cancer (mTNBC). Because of the limited treatment options…
ReviewCase Report
PMID: 39183403
Cell reports. Medicine|2024|Liu K et al.
Although oncolytic adenoviruses are widely studied for their direct oncolytic activity and immunomodulatory role in cancer immunotherapy, the immunosuppressive feedback loop induced by oncolytic adenoviruses remains to be studied. Here, we demonstrat…
PMID: 39357524
International journal of molecular sciences|2024|Espinar-Buitrago M et al.
Resistance and toxicity associated with current treatments for human cytomegalovirus (HCMV) infection highlight the need for alternatives and immunotherapy has emerged as a promising strategy. This study examined the in vitro immunological effects of…
In Vitro
PMID: 38396631
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|2024|Cao A, Feng F, Zhou X
This systematic review was conducted to assess the curative effect of Thymosin alpha 1 in the acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients. Six electronic databases including EMBASE, PubMed, Cochrane Library, China Na…
ReviewMeta-Analysis
PMID: 39648386
African health sciences|2024|Qian J, Sun X, Cheng Y
BACKGROUND: To observe and analyse the clinical effects of entecavir on serum hyaluronic acid (HA), laminin (LN), and type IV collagen (IVC) in patients with hepatitis B e-antigen (HBeAG)-positive chronic hepatitis B during clinical treatment. METHOD…
PMID: 40190501